Literature DB >> 1953677

Domain structure of endothelial heparan sulphate.

A Lindblom1, G Bengtsson-Olivecrona, L A Fransson.   

Abstract

The domain structure of heparan sulphate chains from an endothelial low-density proteoglycan was examined using specific degradations of the chains while attached to the intact proteoglycan. 'Inner' chain fragments, remaining on the protein core, were separated from 'outer' fragments by gel chromatography, and were subsequently released from the protein core by alkaline cleavage. The structure of 'inner' and 'outer' chain fragments was then examined and compared. Using deaminative cleavage we obtained evidence that the first N-sulphated glucosamine residue is variably positioned some 10-17 disaccharides from the xylose-serine linkage of the proteoglycan. Digestion with heparinase yielded 'inner' and 'outer' fragments covering a broad range of different sizes, indicating a scarce and variable distribution of sulphated iduronic acid in the native chains. N-sulphated glucosamine occurred more frequently in the 'outer' fragments. We also studied the affinity of the endothelial heparan sulphate chains towards two presumptive biological ligands, namely antithrombin III and lipoprotein lipase. A major part of the endothelial heparan sulphate chains showed a weak affinity for antithrombin III and the affinity was essentially lost on heparinase digestion. On lipoprotein lipase-agarose the endothelial heparan sulphate chains were eluted at the same salt concentration as heparin, and the binding persisted, although with decreased strength, after digestion with heparinase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1953677      PMCID: PMC1151520          DOI: 10.1042/bj2790821

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin.

Authors:  M Höök; I Björk; J Hopwood; U Lindahl
Journal:  FEBS Lett       Date:  1976-07-01       Impact factor: 4.124

2.  Interaction of heparin with proteins. Demonstration of different binding sites for antithrombin and lipoprotein lipase.

Authors:  G Bengtsson; T Olivecrona
Journal:  FEBS Lett       Date:  1977-07-01       Impact factor: 4.124

3.  Formation of anhydrosugars in the chemical depolymerization of heparin.

Authors:  J E Shively; H E Conrad
Journal:  Biochemistry       Date:  1976-09-07       Impact factor: 3.162

4.  A method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulphate.

Authors:  A Wasteson
Journal:  J Chromatogr       Date:  1971-07-08

5.  Endothelial heparan sulphate: compositional analysis and comparison of chains from different proteoglycan populations.

Authors:  A Lindblom; L A Fransson
Journal:  Glycoconj J       Date:  1990       Impact factor: 2.916

6.  Further characterization of the antithrombin-binding sequence in heparin.

Authors:  L Thunberg; G Bäckström; U Lindahl
Journal:  Carbohydr Res       Date:  1982-03-01       Impact factor: 2.104

7.  A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures.

Authors:  R W Farndale; C A Sayers; A J Barrett
Journal:  Connect Tissue Res       Date:  1982       Impact factor: 3.417

8.  Interaction of lipoprotein lipase with native and modified heparin-like polysaccharides.

Authors:  G Bengtsson; T Olivecrona; M Höök; J Riesenfeld; U Lindahl
Journal:  Biochem J       Date:  1980-09-01       Impact factor: 3.857

9.  Differentiated microdomains on the luminal surface of the capillary endothelium. II. Partial characterization of their anionic sites.

Authors:  M Simionescu; N Simionescu; J E Silbert; G E Palade
Journal:  J Cell Biol       Date:  1981-09       Impact factor: 10.539

10.  Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion.

Authors:  Y S Kanwar; A Linker; M G Farquhar
Journal:  J Cell Biol       Date:  1980-08       Impact factor: 10.539

View more
  5 in total

1.  Heparinase inhibits neovascularization.

Authors:  R Sasisekharan; M A Moses; M A Nugent; C L Cooney; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

Review 2.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

3.  Sulphated and undersulphated heparan sulphate proteoglycans in a Chinese hamster ovary cell mutant defective in N-sulphotransferase.

Authors:  K J Bame; L Zhang; G David; J D Esko
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

4.  Altered expression of antithrombotic molecules in human glioma vessels.

Authors:  T Isaka; T Yoshimine; M Maruno; R Kuroda; H Ishii; T Hayakawa
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  Interaction of size-fractionated heparins with lipoprotein lipase and hepatic lipase in the rat.

Authors:  G Liu; M Hultin; P Ostergaard; T Olivecrona
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.